Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: Partial activity within domain 5

FASEB Journal

Volumn 14, Issue 15, 2000, Pages 2589-2600

  Zhang, J C ^a   Claffey, K ^a   Sakthivel, R ^a   Darzynkiewicz, Z ^a   Shaw, D E ^a   Leal, J ^a   Wang, Y C ^a   Lu, F M ^a   McCrae, K R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Coagulation; Endothelium; Neovascularization; Tumor

Indexed keywords

ANGIOGENESIS INHIBITOR; GROWTH FACTOR; HIGH MOLECULAR WEIGHT KININOGEN; MATRIGEL; TWO CHAIN HIGH MOLECULAR WEIGHT KININOGEN; UNCLASSIFIED DRUG; ZINC;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL TISSUE; AORTA MEDIA; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; CORNEA; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER; TROPHOBLAST; UMBILICAL VEIN;

ANIMALIA;

EID: 0033669311     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.99-1025com     Document Type: Article

References (69)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Angiogenesis
4. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth
5. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
6. Tumor angiogenesis in stage 1B cervical cancer: Correlation of the microvessel density with survival
7. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
8. Pieces of eight: Bioactive fragments of extracellular matrix proteins as regulators of angiogenesis
9. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
10. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells
11. Expression of plasminogen activator inhibitor type 1 by human prostate carcinomas cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model
12. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
13. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
14. Endostatin-an endogenous inhibitor of angiogenesis and tumor growth
15. Antiangiogenic activity of restin, NC10 domain of collagen XV: Comparison to endostatin
16. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
17. The 16 kDa N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
18. Heparin binding fragments of fibronectin are potent inhibitors of endothelial cell growth
19. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
20. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth
21. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive and proinflammatory attributes
22. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin
23. The coagulation-kinin pathway of human plasma
24. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation
25. Studies on human high molecular weight (HMW) kininogen II: Structural change of HMW kininogen by the action of human plasma kallikrein II
26. Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens
27. Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human microvascular endothelial cells
28. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2+3 of the urokinase receptor
29. Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast
30. Mapping the cell binding site on high molecular weight kininogen domain 5
31. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular 'heads' of C1q (gC1q-R)
32. Identification of cytokeratin as a binding protein and presentation receptor for kininogens on endothelial cells
33. Mapping binding domains of kininogens on endothelial cell cytokeratin 1
34. Assay and purification of naturally occurring inhibitor of angiogenesis
35. A corneal micropocket assay for angiogenesis in the rat eye
36. In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis
37. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains
38. The shape of high molecular weight kininogen: Organization into structural domains, changes with activation and interactions with prekallikrein, as determined by electron microscopy
39. 2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells
40. Solid phase peptide synthesis
41. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
42. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
43. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells
44. Proliferation of a human epidermal tumor cell line stimulated by urokinase
45. The binding of high molecular weight kininogen to cultured human umbilical vein endothelial cells
46. Isolation and characterization of the kininogen binding protein p33 from endothelial cells
47. Apoptosis: The role of the endonuclease
48. Recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
49. Suppression of tumor growth with recombinant murine angiostatin
50. Kringle domains of human angiostatin
51. Opposing effects of high and low molecular weight kininogens on cell adhesion
52. Inhibition of cell adhesion by high molecular weight kininogen
53. Integrins and anoikis
54. Integrin signaling and cell growth control
55. The role of integrins in tumorigenesis and metastasis
56. 3: Angiogenesis and apoptosis
57. Integrins: A family of cell surface receptors
58. The hemostatic system as a regulator of angiogenesis
59. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
60. Zinc-dependent dimers observed in crystals of human endostatin
61. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
62. A novel mechanism for bradykinin production at inflammatory sites
63. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to heparin
64. Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions
65. Cleavage of plasma high molecular weight kininogen in surgical ICU patients
66. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies
67. Proteolytic degradation of high molecular weight kininogen in acute thrombotic thrombocytopenic purpura
68. Alterations of the coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris
69. Plasmin-mediated activation of the contact system in response to pharmacological thrombolysis